Thursday, May 30, 2024
HomeBreaking NewsWhy Novavax Stock More Than Doubled Today

Why Novavax Stock More Than Doubled Today

2024-05-10 13:08:23 ET

Shares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker’s first-quarter results. It’s not the report, however, driving the bulk of today’s oversize gain — it’s the announcement made in conjunction with it.

The company is partnering with fellow pharmaceutical company Sanofi (NASDAQ: SNY) to market Novavax’s COVID vaccine. The deal also opens the door to the development of a flu vaccine based on Novavax’s underlying science used to create its coronavirus jab.

For the quarter ending in March, Novavax had $94 million in revenue and a loss of $1.05 per share. These numbers are an improvement on the year-ago loss of $3.41 per share, on $81 million in sales.

Continue reading

For further details see:

Why Novavax Stock More Than Doubled Today


This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of Novavax Inc. (NVAX) and does not buy, sell, or trade any shares of (NVAX). This article does not provide a professional analysis of a (NVAX) financial position. (NVAX) financial position and all other information regarding the featured Company should be verified directly with (NVAX). This website ( has received none USD from N/A for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting N/A ending N/A. Please read our full disclaimer for more detailed information.

Most Popular


Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts